Encorafenib
Brand name: Braftovi
Rank #443 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$17.6M
Total Cost
1,209
Total Claims
$17.6M
Total Cost
70
Prescribers
$15K
Cost per Claim
0
Beneficiaries
1,227
30-Day Fills
$251K
Avg Cost/Provider
17
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$17.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $17.6M total
🔎 Data Overview
At $14,550 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $251,297 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Encorafenib
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Riley Fadden | Nurse Practitioner | Boston, MA | 46 | $794K |
| 2 | Douglas Johnson | Medical Oncology | Nashville, TN | 37 | $573K |
| 3 | Paul Chapman | Medical Oncology | New York, NY | 33 | $549K |
| 4 | Michele Nanni | Physician Assistant | Buffalo, NY | 35 | $510K |
| 5 | Matthew Taylor | Medical Oncology | Portland, OR | 32 | $478K |
| 6 | Aimee Kohn | Medical Oncology | Portland, OR | 31 | $474K |
| 7 | Jason Chesney | Hematology-Oncology | Louisville, KY | 31 | $418K |
| 8 | Caressa Valdueza | Nurse Practitioner | New York, NY | 30 | $406K |
| 9 | Melinda Yushak | Hematology-Oncology | New Haven, CT | 30 | $400K |
| 10 | Isabella Glitza | Internal Medicine | Houston, TX | 25 | $382K |
| 11 | Lalit Aneja | Hematology-Oncology | Venice, FL | 25 | $382K |
| 12 | Harpaul Gill | Hematology-Oncology | Alpharetta, GA | 22 | $370K |
| 13 | Matthew Block | Medical Oncology | Rochester, MN | 30 | $352K |
| 14 | Adi Diab | Medical Oncology | Houston, TX | 22 | $336K |
| 15 | Michele Freesmeier | Physician Assistant | Iowa City, IA | 21 | $319K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
| 445 | Enalapril Maleate (Enalapril Maleate) | $17.5M | 673,317 |
| 446 | Vismodegib (Erivedge) | $17.4M | 1,317 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology